| Primary |
| Hyperlipidaemia |
27.3% |
| Drug Use For Unknown Indication |
21.0% |
| Blood Cholesterol Increased |
15.4% |
| Product Used For Unknown Indication |
10.5% |
| Blood Triglycerides Increased |
4.2% |
| Dyslipidaemia |
3.5% |
| Blood Cholesterol |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| High Density Lipoprotein Increased |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Lipids Abnormal |
1.4% |
| Liver Disorder |
1.4% |
| Blood Cholesterol Decreased |
0.7% |
| Drug Abuse |
0.7% |
| Drug Therapy Enhancement |
0.7% |
| High Density Lipoprotein Abnormal |
0.7% |
| High Density Lipoprotein Decreased |
0.7% |
| Hypertension |
0.7% |
| Hypertriglyceridaemia |
0.7% |
| Ill-defined Disorder |
0.7% |
|
| Flushing |
19.0% |
| Rash |
11.9% |
| Vomiting |
10.7% |
| Rhabdomyolysis |
6.0% |
| Weight Decreased |
6.0% |
| Gout |
4.8% |
| Intraocular Pressure Increased |
4.8% |
| Dizziness |
3.6% |
| Pruritus |
3.6% |
| Skin Burning Sensation |
3.6% |
| Urticaria |
3.6% |
| Vision Blurred |
3.6% |
| Dysgeusia |
2.4% |
| Erythema |
2.4% |
| Headache |
2.4% |
| Hypersensitivity |
2.4% |
| Loss Of Consciousness |
2.4% |
| Malaise |
2.4% |
| Myalgia |
2.4% |
| Paraesthesia |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
22.6% |
| Blood Cholesterol Increased |
20.5% |
| Drug Use For Unknown Indication |
10.7% |
| Hypertension |
10.3% |
| High Density Lipoprotein Decreased |
6.9% |
| Hyperlipidaemia |
5.5% |
| Blood Triglycerides Increased |
4.3% |
| Hypercholesterolaemia |
2.8% |
| Blood Cholesterol |
2.6% |
| Dyslipidaemia |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Dementia Alzheimer's Type |
1.5% |
| Diabetes Mellitus |
1.4% |
| Low Density Lipoprotein Increased |
1.4% |
| Atrial Fibrillation |
1.3% |
| Benign Prostatic Hyperplasia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Anticoagulant Therapy |
0.9% |
| Hypothyroidism |
0.9% |
| Arthralgia |
0.8% |
|
| Rhabdomyolysis |
19.7% |
| Drug Hypersensitivity |
17.6% |
| Myalgia |
5.9% |
| Weight Decreased |
5.3% |
| Flushing |
4.8% |
| Intraocular Pressure Increased |
4.3% |
| Pruritus |
4.3% |
| Renal Failure Acute |
4.3% |
| Rash |
3.7% |
| Vomiting |
3.7% |
| Weight Increased |
3.7% |
| Muscular Weakness |
3.2% |
| Pain In Extremity |
3.2% |
| Respiratory Arrest |
3.2% |
| Insulin Autoimmune Syndrome |
2.7% |
| Feeling Abnormal |
2.1% |
| Hot Flush |
2.1% |
| Hyperhidrosis |
2.1% |
| Rash Generalised |
2.1% |
| Rash Pruritic |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.7% |
| Drug Use For Unknown Indication |
12.0% |
| Hypertension |
7.9% |
| Blood Cholesterol Increased |
6.2% |
| Type 2 Diabetes Mellitus |
4.3% |
| Diabetes Mellitus |
4.2% |
| Pain |
3.5% |
| Prophylaxis |
3.4% |
| Atrial Fibrillation |
3.2% |
| Cardiac Disorder |
2.7% |
| Vitamin Supplementation |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Osteoporosis |
2.4% |
| Depression |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Blood Cholesterol |
2.0% |
| Supplementation Therapy |
1.9% |
| Hyperlipidaemia |
1.6% |
| Anxiety |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
|
| Vomiting |
12.4% |
| Weight Decreased |
11.1% |
| Weight Increased |
8.3% |
| Drug Ineffective |
6.1% |
| Myocardial Infarction |
5.5% |
| Nausea |
5.0% |
| Pain |
4.4% |
| Rash |
4.2% |
| Pain In Extremity |
4.0% |
| Vision Blurred |
4.0% |
| Dyspnoea |
3.9% |
| Death |
3.7% |
| Myalgia |
3.5% |
| Pruritus |
3.5% |
| Urinary Tract Infection |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Fatigue |
3.4% |
| Flushing |
3.3% |
| Headache |
3.3% |
| Renal Failure Acute |
3.3% |
|
| Interacting |
| Antiretroviral Therapy |
11.4% |
| Blood Cholesterol Increased |
11.4% |
| Vitamin Supplementation |
11.4% |
| Blood Cholesterol Abnormal |
6.8% |
| Hypercholesterolaemia |
6.8% |
| Smoking Cessation Therapy |
6.8% |
| Vitamin D Deficiency |
6.8% |
| Anticoagulant Therapy |
4.5% |
| Blood Cholesterol Decreased |
4.5% |
| High Density Lipoprotein Decreased |
4.5% |
| Hypertension |
4.5% |
| Major Depression |
4.5% |
| Pulmonary Hypertension |
4.5% |
| Cardiac Pacemaker Insertion |
2.3% |
| Epilepsy |
2.3% |
| Hiv Infection |
2.3% |
| Hypothyroidism |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
|
| Drug Interaction |
22.7% |
| Vomiting |
18.2% |
| International Normalised Ratio Increased |
9.1% |
| Skin Reaction |
9.1% |
| Vitamin D Deficiency |
9.1% |
| Dizziness |
4.5% |
| Drug Effect Decreased |
4.5% |
| Hepatitis Acute |
4.5% |
| Hyperhidrosis |
4.5% |
| Injection Site Nodule |
4.5% |
| Lipids Abnormal |
4.5% |
| Obstructive Airways Disorder |
4.5% |
|
